Propionic Acid

Propionic Acid

SCHEMBL4153028

CCC(=O)O.O=c1[nH]c2ccc([S+]([O-])Cc3ccccc3)cc2c2cc[nH]c12

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 3/20 0.36
MAPT P10636 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
RXFP1 Q9HBX9 2/20 0.34
PARP1 P09874 1/20 0.34
PIM1 P11309 2/20 0.33
LIMK1 P53667 1/20 0.32
LIMK2 P53671 1/20 0.32
HPGD P15428 2/20 0.32
HSD17B10 Q99714 1/20 0.32
THRB P10828 1/20 0.32
PIM3 Q86V86 1/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4155437 0.81 PPARG (0.46) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4153840 0.79 PIM1 (0.44) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4162521 0.78 FEN1 (0.44) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4171576 0.77 PIM1 (0.46) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4153189 0.77 DAO (0.41) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL3247241 0.76 CYP1A2 (0.36) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4159927 0.76 ALDH1A1 (0.40) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4162445 0.76 AR (0.40) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4165125 0.76 PARP1 (0.47) ALDH1A1KDM4EMAPTMEN1KMT2A
Propionic Acid SCHEMBL4160624 0.76 MPO (0.43) KDM4EPIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 ALDH1A1 3830/4885KDM4E 1970/4885MAPT 734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.